Author/Authors :
Hasegawa، نويسنده , , Bruce H and Barber، نويسنده , , William C and Funk، نويسنده , , Tobias and Hwang، نويسنده , , Andrew B and Taylor، نويسنده , , Carmen and Sun، نويسنده , , Mingshan and Seo، نويسنده , , Youngho، نويسنده ,
Abstract :
In medical diagnosis, functional or physiological data can be acquired using radionuclide imaging with positron emission tomography or with single-photon emission computed tomography. However, anatomical or structural data can be acquired using X-ray computed tomography. In dual-modality imaging, both radionuclide and X-ray detectors are incorporated in an imaging system to allow both functional and structural data to be acquired in a single procedure without removing the patient from the imaging system. In a clinical setting, dual-modality imaging systems commonly are used to localize radiopharmaceutical uptake with respect to the patientʹs anatomy. This helps the clinician to differentiate disease from regions of normal radiopharmaceutical accumulation, to improve diagnosis or cancer staging, or to facilitate planning for radiation therapy or surgery. While initial applications of dual-modality imaging were developed for clinical imaging on humans, it now is recognized that these systems have potentially important applications for imaging small animals involved in experimental studies including basic investigations of mammalian biology and development of new pharmaceuticals for diagnosis or treatment of disease.
Keywords :
Dual-modality imaging , Positron emission tomography (PET) , computed tomography (CT) , Single-photon emission computed tomography (SPECT)